株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の婦人科検診市場の分析

Global Women Health Diagnostics Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 486702
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
世界の婦人科検診市場の分析 Global Women Health Diagnostics Market 2019-2025
出版日: 2019年12月31日 ページ情報: 英文
概要

当レポートでは、世界の婦人科検診市場について調査分析し、市場概要、市場影響要因、地域の規制・政策、市場決定要因、収益予測、主要企業のプロファイルや最近の動向など、体系的な情報を提供しています。

第1章 レポートサマリー

第2章 市場概要と考察

  • 定義
  • アナリスト、現在の市場動向
  • 規制
  • 特許分析

第3章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第4章 市場区分

  • 用途別
  • エンドユーザー別

第5章 競合情勢

  • 主要戦略分析
  • 主要企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 企業プロファイル

  • ABBOTT LABORATORIES
  • ALERE INC.
  • BIOMERIEUX SA
  • BECTON, DICKINSON AND COMPANY
  • DIALAB GMBH
  • F. HOFFMANN-LA ROCHE AG
  • FUJIFILM MEDICAL SYSTEMS USA
  • GE HEALTHCARE
  • GENMARK DIAGNOSTICS
  • HOLOGIC, INC.
  • IMMCO DIAGNOSTICS
  • KONINKLIJKE PHILIPS N.V.
  • LUMINEX CORPORATION
  • NOVA BIOMEDICAL
  • PHILIPS HEALTHCARE
  • PERKINELMER INC.
  • QUEST DIAGNOSTICS INC.
  • ROCHE DIAGNOSTICS
  • SIEMENS AG
  • SOMAGEN DIAGNOSTICS
図表

List of Tables

1. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

2. GLOBAL BREAST CANCER TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL CERVICAL CANCER TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL PREGNANCY & FERTILITY TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL OVARIAN CANCER TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL INFECTIOUS DISEASE TESTINGRESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL ULTRASOUND TESTSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

9. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

11. GLOBAL DIAGNOSTIC AND IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

13. GLOBAL HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

14. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

15. NORTH AMERICAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

16. NORTH AMERICAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

17. NORTH AMERICAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

18. EUROPEAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

19. EUROPEAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

20. EUROPEAN WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

21. ASIA-PACIFIC WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

22. ASIA-PACIFIC WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

23. ASIA-PACIFIC WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

24. REST OF THE WORLD WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

25. REST OF THE WORLD WOMEN HEALTH DIAGNSOTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

List of Figures

1. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

2. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. GLOBAL WOMEN HEALTH DIAGNSOTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. THE US WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

6. UK WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY WOMEN HEALTH DIAGNSOTICS MARKET, 2018-2025 ($ MILLION)

10. SPAIN WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD WOMEN HEALTH DIAGNSOTICS MARKET SIZE, 2018-2025 ($ MILLION)

目次
Product Code: OMR2020079

Global Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others) and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) and Forecast 2019-2025

The global women health diagnostics market is significantly growing during the forecast period. The key factors that are contributing towards the growth of the global women health diagnostic market are increasing incidences of lifestyle-related and chronic disorders in women, rise in the number of imaging centers and private diagnostics, rising prevalence of infectious diseases, and growing adoption of point of care and rapid diagnostic tests. According to the World Health Organization (WHO), around 36.9 million people across the globe are living with HIV and nearly 23.3 million people have received antiretroviral treatment in 2018. Furthermore, increasing incidences of chronic disorders such as breast cancer have raised the need for health diagnostics in women.

Breast cancer is one of the most common cancer types among women at the global level. As per Breast Cancer Research Foundation, in 2018, the breast cancer represents one in four of all cancers in women across the globe; whereas, nearly one in eight women in the US are expected to develop invasive breast cancer during the course of her lifetime. According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer are projected to be diagnosed in women in the US. Such occurrence widens the scope for the growth of global women health diagnostics market. Apart from it, supportive initiatives by government and health organizations and rising awareness about fertility tests have also played a vital role in the growth of the global market. However, lack of skilled laboratory personnel and high cost of procedures and diagnostic imaging systems are the key factors restraining the growth of the market.

The global women health diagnostics market is segmented based on application and end-user. Based on applications, the prenatal testing is expected to hold a major share due to the owing to rising prevalence of prenatal diseases, surging healthcare expenditure, and increasing maternal age. Based on end-user, the diagnostic centers and hospitals accounted for a major share in the market due to the high number of visits to hospitals.

Geographically, the global women health diagnostics market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the global women health diagnostics market due to increasing demand for fertility testing monitors, rising prevalence of cancer, and incidences of lifestyle-related disorders within the region. Furthermore, Asia-Pacific is expected to witness a considerable growth rate in the global women health diagnostics market during the forecast period. The growth is accredited to the rising awareness among women related to several health disorders and increases proportionately income.

The key players operating in the global women health diagnostics market include Abbott Laboratories, Inc., biomerieux SA, Becton, Dickson and Co., DIALAB Gmbh, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corp., Siemens AG, Quest Diagnostics Inc., and General Electric Co. Adoption of growth strategies such as mergers and acquisitions, product launch, partnership, and agreements are the key strategies of major market players. For instance, in January 2017, Abbott Laboratories, Inc. launched a biomedical immunization machine such as Alinityci-series diagnostic systems. The Alinityci-series is easy to use due to the compact size and scalable systems to maximize efficiency and throughput. It enables hospitals and labs to achieve better healthcare performance.

Research Methodology

The market study of the global women health diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for diagnostic solution manufacturers and suppliers for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Women Health Diagnostics Market Research and Analysis by Application.

2. Global Women Health Diagnostics Market Research and Analysis by End-User.

The Report Covers

  • Comprehensive research methodology of the global women health diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global women health diagnostics market.
  • Insights about market determinants which are stimulating the global women health diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. General Electric Co.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Abbott Laboratories, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Siemens AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Becton, Dickinson and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Quest Diagnostics Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

4.1 Motivators

4.2 Restraints

4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Women Health Diagnostics Market by Application
    • 5.1.1. Breast Cancer Testing
    • 5.1.2. Cervical Cancer Testing
    • 5.1.3. Pregnancy & Fertility Testing
    • 5.1.4. Ovarian Cancer Testing
    • 5.1.5. Infectious Disease Testing
    • 5.1.6. Ultrasound Tests
    • 5.1.7. Sexually Transmitted Disease Testing
    • 5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
  • 5.2. Global Women Health Diagnostics Market by End-User
    • 5.2.1. Diagnostic and Imaging Centers
    • 5.2.2. Hospitals and Clinics
    • 5.2.3. Home Care

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Becton, Dickson and Co.
  • 7.3. biomerieux SA
  • 7.4. DIALAB Gmbh
  • 7.5. EKF Diagnostics Holdings PLC
  • 7.6. F. Hoffmann-La Roche Ltd.
  • 7.7. Fujifilm Holdings Corp.
  • 7.8. General Electric Co.
  • 7.9. GenMark Diagnostics, Inc.
  • 7.10. Hologic, Inc.
  • 7.11. Koninklijke Philips N.V.
  • 7.12. Luminex Corp.
  • 7.13. Nova Biomedical Pte. Ltd.
  • 7.14. PerkinElmer Inc.
  • 7.15. QIAGEN N.V.
  • 7.16. Quest Diagnostics Inc.
  • 7.17. Siemens AG
  • 7.18. Somagen Diagnostics Inc.
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. Trinity Biotech PLC
Back to Top